Kansas Bioscience Authority Approves $700,000 in New Investments

The Kansas Bioscience Authority board of directors has approved $700,000 in new investments. The investments include Parnell, an Australian veterinary pharmaceutical company, which received a $400,000 grant and a $300,000 grant to support the establishment in Kansas of a contract research organization by a firm established elsewhere in the country.

North AmericaUSBriefs